Nervous System Active Pharmaceutical Ingredients Market Trends

Growth Drivers

Growing Popularity of Personalized Medicines- The healthcare system is paying more attention to precision medicine since it enables more individualized treatments. Nervous system active pharmaceutical ingredients are utilized in personalized medicine approaches, which is estimated to drive market growth.
Rising Focus on Mental Health- The pandemic also contributed to a greater focus on mental health, which has resulted in a rise in demand for mental health treatments including nervous system active pharmaceutical ingredients.

Challenges

Availability of Counterfeit Drugs– The availability of substandard counterfeit medicines is expected to hinder market growth during the forecast period. For instance, counterfeit drugs are available everywhere around the world and customers find them cost-effective and convenient.
Shortage of the Required Ingredients

Lack of Awareness of Medication

Nervous System Active Pharmaceutical Ingredients Market: Key Insights

Base Year	2022
Forecast Year	2023-2035
CAGR	~5%
Base Year Market Size (2022)	~ USD 200 Billion
Forecast Year Market Size (2035)	~ USD 400 Billion
Regional Scope	North America (U.S., and Canada) Latin America (Mexico, Argentina, Rest of Latin America) Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific) Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe) Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Frequently Asked Questions (FAQ)

The growing presence of chronic diseases across the globe and the growing geriatric population are the major factors driving the growth of the market.

The market size of the Nervous System Active Pharmaceutical Ingredients Market is anticipated to attain a CAGR of 5% over the forecast period, i.e., 2023-2035.

The major players in the market are Boehringer Ingelheim International GmbH, Bristol Myers Squibb Company, Shenzhen Hepalink Pharmaceutical Co. Ltd., GSK plc, F. Hoffmann-La Roche Ltd, Cipla Inc., Eli Lilly and Company, Novartis AG, Teva Pharmaceutical Industries Ltd.

The CVDs segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

Nervous System Active Pharmaceutical Ingredients Market Trends